Silk Road Medical Inc. (SILK) Misses Q4 EPS by 6c, Revenues Beats

Silk Road Medical Inc. (NASDAQ: SILK) reported Q4 EPS of ($0.42), $0.06 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $28.3 million versus the consensus estimate of $25.9 million.

GUIDANCE:

Silk Road Medical Inc. sees FY2022 revenue of $126-132 million, versus the consensus of $133.39 million.

For earnings history and earnings-related data on Silk Road Medical Inc. (SILK) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c